Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Antibody Responses to Fusobacterium nucleatum Proteins in Prediagnostic Blood Samples are not Associated with Risk of Developing Colorectal Cancer.

Butt J, Jenab M, Pawlita M, Overvad K, Tjonneland A, Olsen A, Boutron-Ruault MC, Carbonnel F, Mancini FR, Kaaks R, Kühn T, Boeing H, Trichopoulou A, Karakatsani A, Palli D, Pala VM, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Vermeulen RCH, Weiderpass E, Quirós JR, Duell EJ, Sánchez MJ, Dorronsoro M, Huerta JM, Ardanaz E, Van Guelpen B, Harlid S, Perez-Cornago A, Gunter MJ, Murphy N, Freisling H, Aune D, Waterboer T, Hughes DJ.

Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555. doi: 10.1158/1055-9965.EPI-19-0313.

PMID:
31481495
2.

Pre-diagnostic plasma bile acid levels and colon cancer risk: A prospective study.

Kühn T, Stepien M, López-Nogueroles M, Machado AD, Sookthai D, Johnson T, Roca M, Hüsing A, Maldonado SG, Cross AJ, Murphy N, Freisling H, Rinaldi S, Scalbert A, Fedirco V, Severi G, Boutron-Ruault MC, Mancini FR, Sowah SA, Boeing H, Jakszyn P, Sánchez MJ, Merino S, Colorado-Yohar S, Barricarte A, Khaw KT, Schmidt JA, Perez-Cornago A, Trichopoulou A, Karakatsani A, Thriskos P, Palli D, Agnoli C, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, van Gils CH, Heath A, Gunter MJ, Riboli E, Lahoz A, Jenab M, Kaaks R.

J Natl Cancer Inst. 2019 Aug 21. pii: djz166. doi: 10.1093/jnci/djz166. [Epub ahead of print]

PMID:
31435679
3.

Breast Edema Following Breast-Conserving Surgery and Radiotherapy: Patient-Reported Prevalence, Determinants, and Effect on Health-Related Quality of Life.

Young-Afat DA, Gregorowitsch ML, van den Bongard DH, Burgmans I, van der Pol CC, Witkamp AJ, Bijlsma RM, Koelemij R, Schoenmaeckers EJ, Jonasse Y, van Gils CH, Verkooijen HM.

JNCI Cancer Spectr. 2019 Apr 16;3(2):pkz011. doi: 10.1093/jncics/pkz011. eCollection 2019 Jun.

4.

Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition.

Christakoudi S, Kakourou A, Markozannes G, Tzoulaki I, Weiderpass E, Brennan P, Gunter M, Dahm CC, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Madika AL, Severi G, Katzke V, Kühn T, Bergmann MM, Boeing H, Karakatsani A, Martimianaki G, Thriskos P, Masala G, Sieri S, Panico S, Tumino R, Ricceri F, Agudo A, Redondo-Sánchez D, Colorado-Yohar SM, Mokoroa O, Melander O, Stocks T, Häggström C, Harlid S, Bueno-de-Mesquita B, van Gils CH, Vermeulen RCH, Khaw KT, Wareham NJ, Tong TYN, Freisling H, Johansson M, Lennon H, Aune D, Riboli E, Trichopoulos D, Trichopoulou A, Tsilidis KK.

Int J Cancer. 2019 Jul 18. doi: 10.1002/ijc.32576. [Epub ahead of print]

PMID:
31319002
5.

Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort.

Sarink D, Yang J, Johnson T, Chang-Claude J, Overvad K, Olsen A, Tjønneland A, Fournier A, Mancini FR, Kvaskoff M, Boeing H, Trichopoulou A, Karakatsani A, Valanou E, Agnoli C, Sacerdote C, Masala G, Mattiello A, Tumino R, Van Gils CH, Skeie G, Gram IT, Weiderpass E, Lujan-Barroso L, Petrova D, Santiuste C, Quirós JR, Barricarte A, Amiano P, Travis RC, Gunter M, Dossus L, Christakoudi S, Kaaks R, Fortner RT.

Cancer Epidemiol Biomarkers Prev. 2019 Jul 10. doi: 10.1158/1055-9965.EPI-19-0241. [Epub ahead of print]

PMID:
31292137
6.

Knowledge-based and deep learning-based automated chest wall segmentation in magnetic resonance images of extremely dense breasts.

Verburg E, Wolterink JM, de Waard SN, Išgum I, van Gils CH, Veldhuis WB, Gilhuijs KGA.

Med Phys. 2019 Jul 5. doi: 10.1002/mp.13699. [Epub ahead of print]

PMID:
31274194
7.

The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting.

Gal R, Monninkhof EM, van Gils CH, Groenwold RHH, van den Bongard DHJG, Peeters PHM, Verkooijen HM, May AM.

J Clin Epidemiol. 2019 Sep;113:137-146. doi: 10.1016/j.jclinepi.2019.05.017. Epub 2019 May 28.

8.

Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort.

Assi N, Rinaldi S, Viallon V, Dashti SG, Dossus L, Fournier A, Cervenka I, Kvaskoff M, Turzanski-Fortner R, Bergmann M, Boeing H, Panico S, Ricceri F, Palli D, Tumino R, Grioni S, Sánchez Pérez MJ, Chirlaque MD, Bonet C, Gurrea AB, Amiano Etxezarreta P, Merino S, Bueno de Mesquita HB, van Gils CH, Onland-Moret C, Tjønneland A, Overvad K, Trichopoulou A, Martimianaki G, Karakatsani A, Key T, Christakoudi S, Ellingjord-Dale M, Tsilidis K, Riboli E, Kaaks R, Gunter MJ, Ferrari P.

Int J Cancer. 2019 Apr 10. doi: 10.1002/ijc.32324. [Epub ahead of print]

PMID:
30968961
9.

Change in mammographic density across birth cohorts of Dutch breast cancer screening participants.

Napolitano G, Lynge E, Lillholm M, Vejborg I, van Gils CH, Nielsen M, Karssemeijer N.

Int J Cancer. 2019 Feb 14. doi: 10.1002/ijc.32210. [Epub ahead of print]

PMID:
30762225
10.

Physical activity levels of women with breast cancer during and after treatment, a comparison with the Dutch female population.

Gal R, Monninkhof EM, Peeters PHM, van Gils CH, van den Bongard DHJG, Wendel-Vos GCW, Zuithoff NPA, Verkooijen HM, May AM.

Acta Oncol. 2019 May;58(5):673-681. doi: 10.1080/0284186X.2018.1563712. Epub 2019 Feb 6.

PMID:
30724657
11.

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort.

Sarink D, Schock H, Johnson T, Chang-Claude J, Overvad K, Olsen A, Tjønneland A, Arveux P, Fournier A, Kvaskoff M, Boeing H, Karakatsani A, Trichopoulou A, La Vecchia C, Masala G, Agnoli C, Panico S, Tumino R, Sacerdote C, van Gils CH, Peeters PHM, Weiderpass E, Agudo A, Rodríguez-Barranco M, Huerta JM, Ardanaz E, Gil L, Kaw KT, Schmidt JA, Dossus L, His M, Aune D, Riboli E, Kaaks R, Fortner RT.

BMC Cancer. 2018 Oct 22;18(1):1010. doi: 10.1186/s12885-018-4887-3.

12.

Comprehensive Proteomic Profiling-derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas.

Vos S, Elias SG, van der Groep P, Smolders YH, van Gils CH, van Diest PJ.

Am J Surg Pathol. 2018 Sep;42(9):1262-1272. doi: 10.1097/PAS.0000000000001115.

PMID:
29979200
13.

Reasons for (non)participation in supplemental population-based MRI breast screening for women with extremely dense breasts.

de Lange SV, Bakker MF, Monninkhof EM, Peeters PHM, de Koekkoek-Doll PK, Mann RM, Rutten MJCM, Bisschops RHC, Veltman J, Duvivier KM, Lobbes MBI, de Koning HJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, van Gils CH.

Clin Radiol. 2018 Aug;73(8):759.e1-759.e9. doi: 10.1016/j.crad.2018.04.002. Epub 2018 Jun 18.

PMID:
29759590
14.

The combined effect of mammographic texture and density on breast cancer risk: a cohort study.

Wanders JOP, van Gils CH, Karssemeijer N, Holland K, Kallenberg M, Peeters PHM, Nielsen M, Lillholm M.

Breast Cancer Res. 2018 May 2;20(1):36. doi: 10.1186/s13058-018-0961-7.

15.

Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.

Cairat M, Fournier A, Murphy N, Biessy C, Scalbert A, Rinaldi S, Tjønneland A, Olsen A, Overvad K, Arveux P, Boutron-Ruault MC, Cadeau C, Fortner RT, Kaaks R, Boeing H, Aleksandrova K, Peeters PHM, Van Gils CH, Wareham NJ, Khaw KT, Aune D, Riboli E, Gunter MJ, Dossus L.

Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31570. [Epub ahead of print]

16.

Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.

Schrijver WAME, Suijkerbuijk KPM, van Gils CH, van der Wall E, Moelans CB, van Diest PJ.

J Natl Cancer Inst. 2018 Jun 1;110(6):568-580. doi: 10.1093/jnci/djx273.

PMID:
29315431
17.

Influence of breast compression pressure on the performance of population-based mammography screening.

Holland K, Sechopoulos I, Mann RM, den Heeten GJ, van Gils CH, Karssemeijer N.

Breast Cancer Res. 2017 Nov 28;19(1):126. doi: 10.1186/s13058-017-0917-3.

18.

A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.

Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee IM, Kaaks R, Campa D.

Int J Cancer. 2018 Mar 15;142(6):1182-1188. doi: 10.1002/ijc.31145. Epub 2017 Nov 17.

19.

The effects of exercise on the quality of life of patients with breast cancer (the UMBRELLA Fit study): study protocol for a randomized controlled trial.

Gal R, Monninkhof EM, Groenwold RHH, van Gils CH, van den Bongard DHJG, Peeters PHM, Verkooijen HM, May AM.

Trials. 2017 Oct 27;18(1):504. doi: 10.1186/s13063-017-2252-5.

20.

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.

Vreemann S, Gubern-Mérida A, Schlooz-Vries MS, Bult P, van Gils CH, Hoogerbrugge N, Karssemeijer N, Mann RM.

Radiology. 2018 Feb;286(2):443-451. doi: 10.1148/radiol.2017170458. Epub 2017 Oct 16.

PMID:
29040037
21.

Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients.

Gregorowitsch ML, van den Bongard HJGD, Young-Afat DA, Pignol JP, van Gils CH, May AM, Verkooijen HM.

Breast Cancer Res Treat. 2018 Jan;167(1):205-213. doi: 10.1007/s10549-017-4495-y. Epub 2017 Sep 11.

PMID:
28894982
22.

Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.

Sarink D, Schock H, Johnson T, Overvad K, Holm M, Tjønneland A, Boutron-Ruault MC, His M, Kvaskoff M, Boeing H, Lagiou P, Papatesta EM, Trichopoulou A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HBA, van Gils CH, Peeters PH, Weiderpass E, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Amiano P, Khaw KT, Travis R, Dossus L, Gunter M, Rinaldi S, Merritt M, Riboli E, Kaaks R, Fortner RT.

Cancer Prev Res (Phila). 2017 Sep;10(9):525-534. doi: 10.1158/1940-6207.CAPR-17-0125. Epub 2017 Jul 12.

23.

Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide.

Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, López-Ridaura R, Rice M, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Bukowska A, Nagata C, Stone J, Hopper J, Giles G, Ozmen V, Aribal ME, Schüz J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Dickens C, Hartman M, Chia KS, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V.

PLoS Med. 2017 Jun 30;14(6):e1002335. doi: 10.1371/journal.pmed.1002335. eCollection 2017 Jun.

24.

The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.

Wanders JOP, Holland K, Karssemeijer N, Peeters PHM, Veldhuis WB, Mann RM, van Gils CH.

Breast Cancer Res. 2017 Jun 5;19(1):67. doi: 10.1186/s13058-017-0859-9.

25.

The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands.

Kuijer A, Verloop J, Visser O, Sonke G, Jager A, van Gils CH, van Dalen T, Elias SG.

Ann Oncol. 2017 Aug 1;28(8):1970-1978. doi: 10.1093/annonc/mdx204.

PMID:
28459994
26.

The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA): objectives, design, and baseline results.

Young-Afat DA, van Gils CH, van den Bongard HJGD, Verkooijen HM; UMBRELLA Study Group.

Breast Cancer Res Treat. 2017 Jul;164(2):445-450. doi: 10.1007/s10549-017-4242-4. Epub 2017 Apr 25.

27.

Patients' and Health Care Providers' Opinions on a Supportive Health App During Breast Cancer Treatment: A Qualitative Evaluation.

Young-Afat DA, van Gils CH, Bruinvels DJ, van der Pol CC, Witkamp AJ, Sijtsema S, Jonasse Y, Bijlsma RM, Ausems MG, Bos AM, van den Bongard DH, Verkooijen HM.

JMIR Cancer. 2016 Jun 7;2(1):e8. doi: 10.2196/cancer.5334.

28.

Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.

Charaghvandi RK, van Asselen B, Philippens ME, Verkooijen HM, van Gils CH, van Diest PJ, Pijnappel RM, Hobbelink MG, Witkamp AJ, van Dalen T, van der Wall E, van Heijst TC, Koelemij R, van Vulpen M, van den Bongard HJ.

BMC Cancer. 2017 Mar 9;17(1):181. doi: 10.1186/s12885-017-3144-5.

29.

Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.

Fortner RT, Sarink D, Schock H, Johnson T, Tjønneland A, Olsen A, Overvad K, Affret A, His M, Boutron-Ruault MC, Boeing H, Trichopoulou A, Naska A, Orfanos P, Palli D, Sieri S, Mattiello A, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Peeters PH, Van Gils CH, Weiderpass E, Lund E, Quirós JR, Agudo A, Sánchez MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Key T, Khaw KT, Rinaldi S, Dossus L, Gunter M, Merritt MA, Riboli E, Kaaks R.

BMC Med. 2017 Feb 8;15(1):26. doi: 10.1186/s12916-017-0786-8.

30.

Quantification of masking risk in screening mammography with volumetric breast density maps.

Holland K, van Gils CH, Mann RM, Karssemeijer N.

Breast Cancer Res Treat. 2017 Apr;162(3):541-548. doi: 10.1007/s10549-017-4137-4. Epub 2017 Feb 4.

31.

Volumetric breast density affects performance of digital screening mammography.

Wanders JO, Holland K, Veldhuis WB, Mann RM, Pijnappel RM, Peeters PH, van Gils CH, Karssemeijer N.

Breast Cancer Res Treat. 2017 Feb;162(1):95-103. doi: 10.1007/s10549-016-4090-7. Epub 2016 Dec 23.

32.

Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems.

Burton A, Byrnes G, Stone J, Tamimi RM, Heine J, Vachon C, Ozmen V, Pereira A, Garmendia ML, Scott C, Hipwell JH, Dickens C, Schüz J, Aribal ME, Bertrand K, Kwong A, Giles GG, Hopper J, Pérez Gómez B, Pollán M, Teo SH, Mariapun S, Taib NA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Flugelman AA, Ursin G, Qureshi S, Ma H, Lee E, Sirous R, Sirous M, Lee JW, Kim J, Salem D, Kamal R, Hartman M, Miao H, Chia KS, Nagata C, Vinayak S, Ndumia R, van Gils CH, Wanders JO, Peplonska B, Bukowska A, Allen S, Vinnicombe S, Moss S, Chiarelli AM, Linton L, Maskarinec G, Yaffe MJ, Boyd NF, Dos-Santos-Silva I, McCormack VA.

Breast Cancer Res. 2016 Dec 19;18(1):130.

33.

Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort.

Matejcic M, de Batlle J, Ricci C, Biessy C, Perrier F, Huybrechts I, Weiderpass E, Boutron-Ruault MC, Cadeau C, His M, Cox DG, Boeing H, Fortner RT, Kaaks R, Lagiou P, Trichopoulou A, Benetou V, Tumino R, Panico S, Sieri S, Palli D, Ricceri F, Bueno-de-Mesquita HB, Skeie G, Amiano P, Sánchez MJ, Chirlaque MD, Barricarte A, Quirós JR, Buckland G, van Gils CH, Peeters PH, Key TJ, Riboli E, Gylling B, Zeleniuch-Jacquotte A, Gunter MJ, Romieu I, Chajès V.

Int J Cancer. 2017 Mar 15;140(6):1246-1259. doi: 10.1002/ijc.30536.

34.

Pre-adult famine exposure and subsequent colorectal cancer risk in women.

Brand MP, Peeters PH, van Gils CH, Elias SG.

Int J Epidemiol. 2017 Apr 1;46(2):612-621. doi: 10.1093/ije/dyw121.

35.

Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.

Verschoor AM, Kuijer A, Verloop J, Van Gils CH, Sonke GS, Jager A, van Dalen T, Elias SG.

Breast Cancer Res Treat. 2016 Sep;159(2):357-65. doi: 10.1007/s10549-016-3940-7. Epub 2016 Aug 12.

PMID:
27514397
36.

Consistency of breast density categories in serial screening mammograms: A comparison between automated and human assessment.

Holland K, van Zelst J, den Heeten GJ, Imhof-Tas M, Mann RM, van Gils CH, Karssemeijer N.

Breast. 2016 Oct;29:49-54. doi: 10.1016/j.breast.2016.06.020. Epub 2016 Jul 13.

PMID:
27420382
37.

The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?

van der Velden JM, Verkooijen HM, Young-Afat DA, Burbach JP, van Vulpen M, Relton C, van Gils CH, May AM, Groenwold RH.

Int J Epidemiol. 2017 Feb 1;46(1):96-102. doi: 10.1093/ije/dyw050.

PMID:
27118559
38.

Brief Report: Staged-informed Consent in the Cohort Multiple Randomized Controlled Trial Design.

Young-Afat DA, Verkooijen HA, van Gils CH, van der Velden JM, Burbach JP, Elias SG, van Delden JJ, Relton C, van Vulpen M, van der Graaf R.

Epidemiology. 2016 May;27(3):389-92. doi: 10.1097/EDE.0000000000000435. Erratum in: Epidemiology. 2016 Jul;27(4):e31.

PMID:
27035689
39.

Plasma carotenoids, vitamin C, tocopherols, and retinol and the risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Bakker MF, Peeters PH, Klaasen VM, Bueno-de-Mesquita HB, Jansen EH, Ros MM, Travier N, Olsen A, Tjønneland A, Overvad K, Rinaldi S, Romieu I, Brennan P, Boutron-Ruault MC, Perquier F, Cadeau C, Boeing H, Aleksandrova K, Kaaks R, Kühn T, Trichopoulou A, Lagiou P, Trichopoulos D, Vineis P, Krogh V, Panico S, Masala G, Tumino R, Weiderpass E, Skeie G, Lund E, Quirós JR, Ardanaz E, Navarro C, Amiano P, Sánchez MJ, Buckland G, Ericson U, Sonestedt E, Johansson M, Sund M, Travis RC, Key TJ, Khaw KT, Wareham N, Riboli E, van Gils CH.

Am J Clin Nutr. 2016 Feb;103(2):454-64. doi: 10.3945/ajcn.114.101659. Epub 2016 Jan 20.

PMID:
26791185
40.

International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries.

McCormack VA, Burton A, dos-Santos-Silva I, Hipwell JH, Dickens C, Salem D, Kamal R, Hartman M, Lee CP, Chia KS, Ozmen V, Aribal ME, Flugelman AA, Lajous M, Lopez-Riduara R, Rice M, Romieu I, Ursin G, Qureshi S, Ma H, Lee E, van Gils CH, Wanders JO, Vinayak S, Ndumia R, Allen S, Vinnicombe S, Moss S, Won Lee J, Kim J, Pereira A, Garmendia ML, Sirous R, Sirous M, Peplonska B, Bukowska A, Tamimi RM, Bertrand K, Nagata C, Kwong A, Vachon C, Scott C, Perez-Gomez B, Pollan M, Maskarinec G, Giles G, Hopper J, Stone J, Rajaram N, Teo SH, Mariapun S, Yaffe MJ, Schüz J, Chiarelli AM, Linton L, Boyd NF.

Cancer Epidemiol. 2016 Feb;40:141-51. doi: 10.1016/j.canep.2015.11.015. Epub 2015 Dec 24.

41.

Vegetable and fruit consumption and the risk of hormone receptor-defined breast cancer in the EPIC cohort.

Emaus MJ, Peeters PH, Bakker MF, Overvad K, Tjønneland A, Olsen A, Romieu I, Ferrari P, Dossus L, Boutron-Ruault MC, Baglietto L, Fortner RT, Kaaks R, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Pala V, Panico S, Tumino R, Polidoro S, Skeie G, Lund E, Weiderpass E, Quirós JR, Travier N, Sánchez MJ, Chirlaque MD, Ardanaz E, Dorronsoro M, Winkvist A, Wennberg M, Bueno-de-Mesquita HB, Khaw KT, Travis RC, Key TJ, Aune D, Gunter M, Riboli E, van Gils CH.

Am J Clin Nutr. 2016 Jan;103(1):168-77. doi: 10.3945/ajcn.114.101436. Epub 2015 Nov 25.

PMID:
26607934
42.

Geographic variation in volumetric breast density between screening regions in the Netherlands.

van der Waal D, Emaus MJ, Bakker MF, den Heeten GJ, Karssemeijer N, Pijnappel RM, Veldhuis WB, Verbeek AL, van Gils CH, Broeders MJ.

Eur Radiol. 2015 Nov;25(11):3328-37. doi: 10.1007/s00330-015-3742-z. Epub 2015 Jul 3.

43.

MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design.

Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, Bisschops RH, Veltman J, Duvivier KM, Lobbes MB, Pijnappel RM, Karssemeijer N, de Koning HJ, van den Bosch MA, Monninkhof EM, Mali WP, Veldhuis WB, van Gils CH.

Radiology. 2015 Nov;277(2):527-37. doi: 10.1148/radiol.2015141827. Epub 2015 Jun 23.

PMID:
26110667
44.

The effect of weight change on changes in breast density measures over menopause in a breast cancer screening cohort.

Wanders JO, Bakker MF, Veldhuis WB, Peeters PH, van Gils CH.

Breast Cancer Res. 2015 May 30;17:74. doi: 10.1186/s13058-015-0583-2.

45.

Pre-diagnostic concordance with the WCRF/AICR guidelines and survival in European colorectal cancer patients: a cohort study.

Romaguera D, Ward H, Wark PA, Vergnaud AC, Peeters PH, van Gils CH, Ferrari P, Fedirko V, Jenab M, Boutron-Ruault MC, Dossus L, Dartois L, Hansen CP, Dahm CC, Buckland G, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Key TJ, Trichopoulou A, Tsironis C, Lagiou P, Masala G, Pala V, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Ohlsson B, Jirström K, Wennberg M, Nilsson LM, Weiderpass E, Kühn T, Katzke V, Khaw KT, Wareham NJ, Tjønneland A, Boeing H, Quirós JR, Gunter MJ, Riboli E, Norat T.

BMC Med. 2015 May 7;13:107. doi: 10.1186/s12916-015-0332-5.

46.

Alcohol intake and breast cancer in the European prospective investigation into cancer and nutrition.

Romieu I, Scoccianti C, Chajès V, de Batlle J, Biessy C, Dossus L, Baglietto L, Clavel-Chapelon F, Overvad K, Olsen A, Tjønneland A, Kaaks R, Lukanova A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Lund E, Skeie G, Weiderpass E, Quirós García JR, Chirlaque MD, Ardanaz E, Sánchez MJ, Duell EJ, Amiano P, Borgquist S, Wirfält E, Hallmans G, Johansson I, Nilsson LM, Khaw KT, Wareham N, Key TJ, Travis RC, Murphy N, Wark PA, Ferrari P, Riboli E.

Int J Cancer. 2015 Oct 15;137(8):1921-30. doi: 10.1002/ijc.29469. Epub 2015 Jul 14.

47.

Coffee and tea consumption and risk of pre- and postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study.

Bhoo-Pathy N, Peeters PH, Uiterwaal CS, Bueno-de-Mesquita HB, Bulgiba AM, Bech BH, Overvad K, Tjønneland A, Olsen A, Clavel-Chapelon F, Fagherazzi G, Perquier F, Teucher B, Kaaks R, Schütze M, Boeing H, Lagiou P, Orfanos P, Trichopoulou A, Agnoli C, Mattiello A, Palli D, Tumino R, Sacerdote C, van Duijnhoven FJ, Braaten T, Lund E, Skeie G, Redondo ML, Buckland G, Pérez MJ, Chirlaque MD, Ardanaz E, Amiano P, Wirfält E, Wallström P, Johansson I, Nilsson LM, Khaw KT, Wareham N, Allen NE, Key TJ, Rinaldi S, Romieu I, Gallo V, Riboli E, van Gils CH.

Breast Cancer Res. 2015 Jan 31;17:15. doi: 10.1186/s13058-015-0521-3.

48.

Degree of urbanization and mammographic density in Dutch breast cancer screening participants: results from the EPIC-NL cohort.

Emaus MJ, Bakker MF, Beelen RM, Veldhuis WB, Peeters PH, van Gils CH.

Breast Cancer Res Treat. 2014 Dec;148(3):655-63. doi: 10.1007/s10549-014-3205-2. Epub 2014 Nov 16.

PMID:
25399231
49.

Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition: a nested case-control study: plasma micronutrients and pancreatic cancer risk.

Jeurnink SM, Ros MM, Leenders M, van Duijnhoven FJ, Siersema PD, Jansen EH, van Gils CH, Bakker MF, Overvad K, Roswall N, Tjønneland A, Boutron-Ruault MC, Racine A, Cadeau C, Grote V, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Benetou V, Valanou E, Palli D, Krogh V, Vineis P, Tumino R, Mattiello A, Weiderpass E, Skeie G, Castaño JM, Duell EJ, Barricarte A, Molina-Montes E, Argüelles M, Dorronsoro M, Johansen D, Lindkvist B, Sund M, Crowe FL, Khaw KT, Jenab M, Fedirko V, Riboli E, Bueno-de-Mesquita HB.

Int J Cancer. 2015 Mar 15;136(6):E665-76. doi: 10.1002/ijc.29175. Epub 2014 Sep 17.

50.

Assessment of a fully automated, high-throughput mammographic density measurement tool for use with processed digital mammograms.

Couwenberg AM, Verkooijen HM, Li J, Pijnappel RM, Charaghvandi KR, Hartman M, van Gils CH.

Cancer Causes Control. 2014 Aug;25(8):1037-43. doi: 10.1007/s10552-014-0404-4. Epub 2014 Jun 25.

PMID:
24962023

Supplemental Content

Loading ...
Support Center